top of page

Dr. Robert Malone | Lionbliss

Updated: Apr 25, 2022


Dr. Robert Wallace Malone (born 1959) is an American physician and biochemist. His early work focused on mRNA technology,[3] pharmaceuticals, and drug repurposing research.

"My mission is to ensure vaccine safety, make sure that children are protected, stop and/or limit the vaccine mandates, to identify and teach about lifesaving treatments for COVID-19 and other pandemics. My goal is to save lives."

*SUSPENDED from Twitter*

*SUSPENDED from LinkedIn*

The Malone Doctrine

A Declaration of Independence From The Decisions of Institutions That Lack Integrity

We The Undersigned:

  • Demand that all underlying data that contributes to a body of work under consideration must be made available and must remain accessible for analysis.

  • Proclaim the value of knowledge to society is not determined by any given creator of information. Instead, that it is the beneficiaries of knowledge who assign value to a proposition only through thorough critique and relentless scrutiny.

  • Establish the free and open exchange of information and establish as a duty the authority to serve as the custodians of all data forming the basis of our decisions.

  • Require the full disclosure of all sources of funding regarding any citation noted or references made pertaining to any matter under consideration.

  • Commit to impartiality in consideration of all analytical information and data brought before us and expect the same from all others.

  • Foster rigorous open debate and scrutiny in consideration of and for any matter of concern.

  • Shall promptly make the discovery of intellectual dishonesty or professional irresponsibility known to all.

  • Ensure the health, welfare and safety of any whistleblower, bringing forth and/or making public an abrogation of the beliefs held herein.

  • Stand in opposition to censorship and will not accept representations of parties holding within themselves values that conflict with principles of free expression.

  • Deny no person the right to challenge, debate, petition, redress, examine or protest with facts and evidence any decision of this body.


In the late 1980s, while a graduate student researcher at the Salk Institute for Biological Studies in San Diego, California, Malone conducted studies on messenger ribonucleic acid (mRNA) technology, discovering in a landmark experiment that it was possible to transfer mRNA protected by a liposome into cultured cells to signal the information needed for the production of proteins.[3][11][4] In 1987, Malone performed experiments on the transfection of RNA into human, rat, mouse, Xenopus, and Drosophila cells, work which was published in 1989.[3][12] A follow-up study also published in 1989 found that frog embryos absorbed such mRNA. A 1990 paper, in collaboration with Jon A. Wolff, Dennis A. Carson, and others, first suggested the possibility of synthesizing mRNA in a laboratory to trigger the production of a desired protein.[13] These studies are recognized as among the earliest steps towards mRNA vaccine development.[3][14][15][16] Malone claims to be the inventor of mRNA vaccines, and while Stan Gromkowski, an early mRNA vaccine researcher and cellular immunologist, views Malone as "an underappreciated pioneer" who could be in contention to win a Nobel Prize for his work,[1] credit for the distinction is more often given to later advancements by Katalin Karikó and Drew Weissman[17][3] or Moderna co-founder Derrick Rossi,[11][18][19] and was ultimately the result of the contributions of hundreds of researchers, including Malone.[20] Malone has served as director of clinical affairs for Avancer Group, assistant professor at the University of Maryland, Baltimore school of medicine, and an adjunct associate professor of biotechnology at Kennesaw State University.[21] He was CEO and co-founder of Atheric Pharmaceutical,[22] which in 2016 was contracted by the U.S. Army Medical Research Institute of Infectious Diseases to assist in the development of a treatment for the Zika virus by evaluating the efficacy of existing drugs.[23][24][25][26] Until 2020, Malone was chief medical officer at Alchem Laboratories, a Florida pharmaceutical company.[27]


bottom of page